Probe is pleased to announce that it has supplied MicroEye to Department of Clinical Pharmacy, Isala in Zwolle, Netherlands as part of a study to monitor blood and tissue levels of flucloxacillin in patients with a staphylococcus aureus bacteremia.
Category: Company news
Probe has entered into an agreement with Aston University to assist with new application research and analysis.
Probe Scientific has been awarded funds under the SMEE scheme for a short term study at Coventry University.
Exciting news from Probe’s NanoDem project to develop a novel therapeutic drug monitoring point-of-care-testing device for the measurement of immunosuppressants in transplanted patients, based on the MicroEye®.
Probe Scientific signs major development and licence agreements with A. Menarini Diagnostics, multi-national healthcare company, part of the Menarini Group.